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ABSTRACT 
It is evident that nurses from a variety of clinical backgrounds are entering the prescribing 
programme and these nurses are prescribing medicines across a broad range of therapy areas. 
A number of studies have explored the educational preparation for the prescribing role and 
findings include variations across programmes with regards to course content and concerns 
surrounding the support provided by designated medical practitioners.   
Aim 
To explore the views of doctors and nurses, who care for people with diabetes, about the 
prescribing programme. 
Design and methods 
Interviews with 10 nurse prescribers, 9 doctors and 3 non nurse prescribers were conducted in 
9 case study sites across England between October 2007 and September 2008. 
Findings   
Prescribing was seen as a natural extension of advanced nursing roles. Nurses considered it 
important to obtain sound knowledge in areas in which they intended to prescribe prior to 
undertaking the course. Variation across prescribing programmes with regards to the level of 
work required of students and the way in which courses were run were reported. Most doctors 
thought it beneficial for nurses to be involved in mentorship, although doctors continued 
involvement was considered necessary.  
Conclusion 
Prescribing supports advanced nursing practice. Nurses considering undertaking the 
prescribing course need to be aware of the variations across prescribing programmes with 
regards to the level of work required. There is support for joint mentorship between nurse 
prescribers and doctors for students undertaking taking the prescribing course.  
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THE STUDY 
 
INTRODUCTION 
Training for the dual qualification of Nurse Independent Prescribing (NIP)NIP/Nurse 
Supplementary Prescribing (NSP) was introduced in 2003. In the majority of universities and 
higher education institutions (HEIs) that run the prescribing programme, this learning is 
shared between other healthcare professionals who have prescribing powers (i.e. pharmacists 
and allied health professionals). Provided medicines are within the nurses area of competence, 
qualified nurse prescribers have been able to independently prescribe any licensed medicines 
(and some controlled drugs) and any medicine as a supplementary prescriber since 2006. 
Nurses using supplementary prescribing must do so in partnership with a doctor and patient 
and medicines must be listed in the patient’s clinical management plan.  
 
Preparation for the prescribing role comprises 27 taught days (although many programmes 
include a distant learning element) and 12 days learning in practice with a designated medical 
practitioner (DMP) over a 6 month period. Necessary course pre-requisites for nurses include: 
 
 The ability to study at level 3 or degree level 
 A minimum of 3 years experience as a qualified nurse of which the year immediately 
preceding the prescribing course must be in the area that the candidate will prescribe 
 A DMP (with experience or training in teaching and/or supervising in practice) 
prepared to supervise them through the 12 days prescribing in practice 
 Manager’s agreement to undertake the course 
 Be in a role in which upon qualifying would be expected to prescribe (Nursing and 
Midwifery Council (NMC) 2006) 
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Applicants must also demonstrate they are competent to undertake a patient history, and a 
clinical assessment and diagnosis (NMC 2006). 
 
Several studies evaluating nurse prescribing have also looked at the training and preparation 
for this role. Cooper et al (2008), exploring the views of stakeholders involved in 
supplementary prescribing policy, training and practice undertook 43 semi-structured 
interviews with nurse and pharmacist supplementary prescribers, doctors, patient group 
representatives, academics and policy developers. Although stakeholders generally viewed 
supplementary prescribing positively, negative aspects of the prescribing programme related 
to limited timescale and content of the course, the lack of courses tailored to individual 
clinical specialities and variations between courses. Some nurses and pharmacists reported 
DMPs dilatory attitude towards supervision and a number of lecturers gave examples of 
retrospective or cursory signing of competency documents by DMPs.   
 
The adequacy of the role of the DMP was examined by Ryan-Woolley (2007) in a postal 
survey of 1575 Macmillan nurses. Although only 12% of the sample were qualified 
prescribers, a quarter of these nurses said that the support they had received from the DMP 
during the prescribing course was inadequate. The criteria for selecting a DMP was explored 
by George et al (2008) in 2 focus groups (n=5&7) of supplementary prescribing pharmacists 
and telephone interviews with 13 DMPs. It was evident from the findings that the main 
criterion was prior working relationships rather than previous mentoring experience, as set out 
by the Royal Pharmaceutical Society of Great Britain (RPSGB 2006). Support for nurse 
prescriber’s involvement in the supervision of prescribing students is provided by Wells et al 
(2009). Nearly 30% of the 103 Irish mental health nurses completing a 13 item questionnaire 
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reported that they would like to be supervised by a clinical nurse specialist trained in 
prescribing. Only 17% of respondents favoured being supervised in their prescribing practice 
by their consultant psychiatrist.   
 
It is evident (Courtenay & Gordon 2009) that nurses from a broad range of clinical 
backgrounds are entering the prescribing programme and these nurses are prescribing 
medicines across a number of therapy areas. It is therefore important to explore their views 
and experiences of the preparation for the prescribing role and also the views of those who 
have been involved in this preparation.  
 
Aim 
To explore the views of doctors and nurses, who care for people with diabetes, about the 
prescribing programme. 
 
Design 
A 2 stage study was undertaken to explore the treatment management of people with diabetes 
by NIP/NSPs. Stage 1 comprised a national questionnaire survey of NIP/NSPs. A collective 
case study design (Stake 1998), using multiple methods to collect data across 9 case studies of 
practice settings in which nurses prescribed medicines for people with diabetes, was 
employed in stage 2.  Case sites were purposively selected on the basis of findings from the 
national survey in order to be representative of the settings in which nurses were prescribing 
for people with diabetes. This paper reports on a subset of data i.e. interview data with nurse 
prescribers, doctors and non-nurse prescribers (NNPs), collected during stage 2 of this study.  
.  
Participants 
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Within each of the 9 sites, interviews were undertaken with nurse prescribers (n=10), a 
purposive sample of doctors (n=9) who supervised or supported a nurse prescriber, and NNPs 
(n=3) who worked alongside the nurse prescriber (see Table 1). Of the nurse prescribers, there 
were 4 Diabetes Specialist Nurses (DSNs), 4 nurse practitioners and 2 practice nurses. Of the 
9 doctors, 3 were consultants in diabetes and 6 were general practitioners. Six had acted as the 
DMP responsible for educating and assessing a nurse through the prescribing course. Of the 3 
NNP participants, 1 worked in a hospital setting and 2 in general practice.  
 
Data collection  
Issues identified in a review of the literature and findings from the completed national survey 
(Courtenay & Carey 2008) informed the interview schedules. Topics included the extent to 
which the prescribing programme met nurses’ needs, how the course affected practice, 
whether or not the programme could be improved, and the views on doctors adopting the role 
of DMP. Interviews were conducted by two researchers (NC and KS) between October 2007 
and September 2008. 
 
Data analysis and rigour 
Thematic analysis was conducted on the interview data (Braun & Clarke 2006, Pope et al. 
2006). ATLAS.ti qualitative data analysis software was used to manage the initial coding and 
categorising of data. This was followed by discussion and identification of cross-cutting 
patterns and themes. Data saturation was achieved. Reliability was enhanced by the 
independent assessment of transcripts by two skilled qualitative researchers. Differences were 
minor and were consolidated through discussion.  
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Ethical considerations 
The study was approved by university and National Health Service research ethics 
committees. Nurse prescribers who participated in the national survey were asked to indicate 
if they would be interested in participating in stage 2 of the research. Those that expressed an 
interest, and met the sampling criteria, were contacted to confirm their willingness. An 
introductory letter and the project protocol were given to participants once managers had 
agreed that they could participate. Doctors and NNP were first approached by the nurse 
prescriber in each case site, given an information sheet and asked if they were willing to 
participate. The researcher then arranged interview dates and also provided further 
explanation about the study and was able to answer any queries. Participation was voluntary 
and data made anonymous to protect the identity of participants or location of case sites.  
 
FINDINGS 
 
Analysis resulted in 3 themes: 1) Advancing nurse roles 2) Course content 3) Mentoring role 
Themes are illustrated by quotations that have been anonymised and coded according to 
profession and case study site. Abbreviations are Dr = doctor, NNP = non prescribing nurse, 
NP=nurse prescriber.  
 
 
Advancing nurse roles  
 
Prescribing was viewed positively by nurses and the prescribing programme was thought to 
be a natural progression for advanced nurses wishing greater autonomy. This is expressed in 
the following quotes: 
 
 “I think it is a natural progression because if you look at the role of the nurse now, 
 even in a hospital setting, they probably don’t have as much access to doctors as when 
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 I started training. I think for us to be recognised as a profession, with autonomy in 
 each respected area. Again I think a senior nurse who has got the necessary 
 qualification I think it is a natural progression for nurses in all different areas to be 
 able to prescribe, especially the senior nurses. So I think it is quite fitting with the 
 changing of nursing” (CS8 NNP) 
 
 “I think the nursing role has advanced, practice nursing itself is an advanced role, and 
 I think nurse prescribing is a basic essential, certainly within the way I particularly 
 work in this practice, and we are concentrating on chronic disease management and so 
 on, it is an absolute natural thing to do. I think the way it has advanced or the way it 
 could be perceived as being advanced is that you are reaching these decisions by using 
 all those consultation skills that you may not have had the chance to learn and 
 understand and develop in just the nursing”. (CS3 NP).  
 
All nurses (apart from one) worked in a setting with multiple prescribers. For those working 
in general practice, the view was that nurses needed to acquire specialist knowledge and skills 
by completing disease specific modules before they undertook the prescribing course:   
 
 “They have all got some interest in it and understanding that they will do it at some 
 stage but I think everybody recognises that you have got to get the ground work in 
 first on the areas of specialism so you have got your minor injury, you have got the 
 diabetes, you have got the asthma. Because you can’t really prescribe in those areas if 
 you haven’t done the ground work. So at the moment we are concentrating, we have 
 got one nurse doing her diabetic course at Warwick; we have just had two go through 
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 the asthma and chronic obstructive pulmonary disease, I think everybody has now 
 done minor injury and so on”(CS3 NP).  
 
When asked if they felt under any pressure to undertake the prescribing course, the two NNPs 
based in general practice reported no pressure:  
 
 “None whatsoever, from the GPs or colleagues, they have viewed it as very much a 
 personal thing and because I have specialist interests in other things as well as the 
 diabetes, for example wound care, leg ulcer management and that sort of thing, they 
 are letting me do the sorts of things I want to do, but I know if I wanted to do that I 
 could ask at appraisal and I would be allowed to” (CS8 NNP) 
 
In contrast, the non-prescribing DSN felt that there was pressure on nurses working at 
specialist level to undertake the prescribing qualification: 
 
 “I think there is a lot of pressure on all the specialist nurses at the moment. You feel 
 quite, not necessarily undervalued, but I suppose you feel like you have to do it to 
 move on ...” (CS7 NNP) 
 
 
 
 
Course content 
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Nurses reported that the prescribing course provided students with both generic and specialist 
prescribing information. Not all aspects of the course were relevant to the areas in which 
nurses subsequently prescribed. However they found this information valuable:  
 
 “The nurse prescribing course has itself been quite useful up to a point, but as a nurse 
 specialist it probably wasn’t ideally suited to a specialized sort of role, it was much 
 more generic” (CS4 NP) 
 
 “It was comprehensive (the course) in all aspects of prescribing not just the individual 
 specialities, it covered things that I wouldn’t normally do in practice, for instance pain 
 relief, minor injuries, the areas that I don’t normally specialise in. But it was all 
 covered, and I think that was actually extremely valuable and I think it highlighted 
 other areas. Sometimes that will feed into my prescribing because I now have some 
 awareness. It won’t necessarily make me actually write the prescription for that 
 patient” (CS3 NP). 
 
Some nurses had taken the course a number of years previously and there was a recognition 
that the course structure and content had since changed. Doctors and 1 NNP reported that 
there appeared to be variation across prescribing programmes with regards to the level of 
work required of students and the way in which courses were run in different universities. 
This is illustrated in the following quotes:  
 
 “I think the courses appear to have become more difficult as time goes on, that is the 
 feedback I get from colleagues who’ve kind of gone through it. You know the first 
 colleague who went through it compared to the most recent colleague, there is a very 
 big difference in the level of work that is required for it” (CS7 NNP)    
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 “The nurses who did it through X seemed to have a much easier root through to get 
 their certificate at the end, and it was done in a helpful way, Whereas the course in Y 
 seemed to be terrible in that the people on that course weren’t given very clear 
 instructions of what was expected of them. They were expected to do tons of reading 
 up and hours and hours as if they had no other work to do. It was demoralising for a 
 lot of them. There was a very high failure rate and they were never quite sure of the 
 parameters they were being checked on”. (CS6 Dr)  
 
  
Mentoring role 
 
Most nurses reported that doctors were very supportive in their role as DMP during the 
prescribing programme (although one nurse reported problems with obtaining access to the 
DMP).   
 
 “I talked to them [doctors about nurse prescribing] said that I hoped to do it and what I 
 envisioned it would help me do etc. Then I got on the course and the senior partner 
 was my mentor so I went to him and of course I spent quite a lot of time with 
 him. He was excellent; he came to the university for all the meetings. I wasn’t 
 aware of any opposition to it or difficulties at all”. (CS9 NP) 
 
 “I suppose the team that I work with have been very supportive. The consultant was 
 very pro active in supporting us with prescribing and was my mentor for the course”. 
 (CS4 NP) 
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The majority (8/9) of doctors were happy with the idea that nurse prescribers could play a role 
in mentoring nurses through the prescribing programme and thought nurses would benefit 
from the experience of others who have undertaken the course. The majority were also of the 
opinion that doctors continue to be involved in mentorship because of the depth and breadth 
of knowledge they hold, the necessity for maintaining standards and the complexity of 
prescribing in diabetes. This is expressed in the following quotes: 
 
 “I think that (nurse prescribers mentoring students) would be very useful because they 
 will have been through it so they will know the questions, quandaries and dilemmas. I 
 don’t think it should just be nurse prescribers that are doing it but I think they would 
 have a very valuable role in using their experience, how they learnt and what the 
 problems were. I would be in favour of that” (CS8 Dr).  
 
“I don’t see why they [nurses] shouldn’t. It makes sense to have people who have 
actually done  the course and know exactly what they are talking about to know what 
the expectations are in terms of standards and all the rest of it.” (CS4 Dr) 
 
“I think so yes (expect a doctor to act as mentor), mainly because of the breadth of 
knowledge and complexity of some of the areas really. Having said that I would not 
have a problem with our nurse specialists now mentoring other nurses into the same 
role (CS 7 Dr). 
 
  
 
DISCUSSION 
 13
The collective case-study approach adopted in this study did not seek to enable statistical 
generalisation of findings.  The views about the prescribing programme presented are those of 
nurse prescribers, doctors, and NNP involved in the care of people with diabetes. They are not 
representative of health professionals in general.  
 
Nurses in our study were of the opinion that over recent years the role of the nurse had 
changed. Nurses were adopting more advanced roles and new ways of working which 
required them increasingly to work autonomously. Prescribing was seen as a natural extension 
of these advanced roles which enabled and supported new ways of working. Nurses working 
in general practice reported that they did not experience any pressure to undertake prescribing 
training. These nurses had a range of interests in other specialist areas as well as diabetes and 
it was recognised that before they could become prescribers, there was a need to acquire 
specialist knowledge and skills through additional specialist modules. 
 
GPs were said to be supportive of prescribing training, however, the decision to become a 
prescriber, was very much a matter of personal choice for the nurse. This was in contrast to 
the diabetes specialist nurse who reported that the prescribing qualification was seen as a 
necessary qualification for career progression and therefore there was a lot of pressure for 
them to prescribe. It is evident that DSNs are taking on advanced roles which are increasingly 
involving medicines management (James et al 2009). With the development of advanced 
nursing roles in diabetes, it may be that prescribing is becoming an essential requirement of 
the DSN role. This may account for the pressure experienced by the DSN in our study to 
undertake the prescribing programme. 
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Nurses in our study reported that the prescribing course provided students with generic 
prescribing information and covered therapy areas (such as minor illnesses and minor 
injuries) outside of their specialist area of practice. A lack of specialist content has been 
reported previously (Cooper et al 2008, Ryan-Woolley 2007, Goswell & Siefer 2009, 
Courtenay & Carey 2008). Of the 1575 Macmillan nurses surveyed by Ryan-Woolley (2007) 
30% of the 70 prescribers in the sample reported that they had concerns around the lack of 
relevance of the prescribing course to cancer and palliative care. Similarly, 50% of the 439 
nurses (who prescribed for people with diabetes) surveyed by Courtenay & Carey (2008) 
reported that the prescribing programme and the 12 days medical practice support did not 
meet their needs with respect to diabetes. However, these findings are in contrast to nurse 
prescribers in our study who reported that this generic prescribing information was extremely 
valuable with regards to the medical management of this group.  
 
Doctors and NNP reported that prescribing programmes varied. Clinical specialist knowledge 
and variations between courses has recently been reported by Cooper et al (2008). However, 
the variations raised by participants in our study appeared to be related to the amount of study 
hours required of students, and the support provided with regards to the clarity of parameters 
within which students were assessed.  In addition, it was also highlighted by NNPs in our 
study that the expectations of more recent cohorts of prescribing students seemed to be higher 
than for those undertaking earlier courses. A possible explanation for this is that since the 
inception of the prescribing programme, many universities and HEIs have incorporated the 
prescribing module into post qualify pathways such as the nurse practitioner course. In some 
instances, the number of academic credits awarded has increased and, are available at masters 
level. Such an increase would account for the rise in expectations of students. This is 
something that nurses should consider prior to undertaking the prescribing course.  
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Nurses in our study largely reported that doctors were very supportive in their role as mentor 
during the prescribing programme.  This is in contrast to Cooper et al (2008) and Ryan-
woolley et al (2007) who reported inadequacies around the DMP role. Although doctors in 
our study believed that they should continue to be involved in mentorship because of their 
breadth and depth of knowledge and the complexities surrounding prescribing in diabetes, the 
majority were of the opinion that it would be beneficial if nurse prescribers were to play a role 
in mentoring nurses through the prescribing course.  
  
CONCLUSION 
Prescribing supports advanced nursing practice. Nurses considering undertaking the 
prescribing course need to be aware of the variations across prescribing programmes with 
regards to the level of work required. There is support for joint mentorship between nurse 
prescribers and doctors for students undertaking taking the prescribing course 
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 Table 1: Data collected from each case site  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Code NP=Nurse Practitioner, PN=Practice Nurse, Diabetes Specialist Nurse = DSN, GP = General Practice, 
Hospital = HP, Community Clinic = CC 
 
Interviews Case 
Site 
Job Title Setting Number 
of 
nurses 
Nurse 
prescriber 
Doctor Non-nurse 
prescriber 
1 NP GP 1 1 1 0 
2 DSN HP 1 1 1 0 
3  PN GP 1 1 1 0 
4 DSN CC 1 1 1 0 
5 NP GP 1 1 1 0 
6 NP GP 2 2 1 1 
7 DSN HP 1 1 1 1 
8 PN GP 1 1 1 1 
9 DSN CC 1 1 1 0 
Total 10 10 10 9 3 
